ELATION WITH GH SECRETION AFTER TRH ADMINISTRATION.
The frequency of GH elevation observed in subjects with IDDM prompted us to look for pituitary autoantibodies. An indirect immunofluorescence technique utilizing human and guinea pig hypophysis was used to detect their presence in GH, TSII, and prolactin pituitary cells. Studies are now in progress to discriminate these specific endocrine cells autoantibodies. 26 subjects (12 boys, 14 girls, ages 7-20, mean age 12 1 yr) were tested after TRtl administration (7 pg/kg i.v., max. 200 pg). In controls, none had a significant response of plasma Gti as defined by an increase to at least twice the baseline levels and greater than 5 ng/ml. In IDDM children, a significant GH elevation was observed in 17 of 26 cases ( 9 girls, 8 boys) with a mean + SE level of 17.1 + 2.9 ng/ml (range 7.2 -39 ng/ml) (p<0.02 witE normal). Among th; responders to TRH, 14/17 had positive serum pituitary autoantibodies, while in the 9 children with no GH response to TRH, 7/9 had a negative determination. However, it is of interest to note that all patients except one had positive islet-cell antibodies in their serum In conclusion, these results are in agreement with the known paradoxical response of GH after TRH in IDDM patients, but not with the lower incidence reported in adult females. In addition, the study of pituitary autoimmunity could partly explain the changes in GH secretion observed in IDDM patients.
Breakdown o f ORB i s reported as o n e o f t h e earliest retinal c h a n g e s i n adult diabetic patients (Cunha-Vaz.lg75).
I n t h i s s t u d y w e investigated u h e t h e r vitreous fluorophotometry (VFPT) may permit t h e detection similar c h a n g e s in young patients. T h e permeability o f ORB w a s examined by V F P H i n 3 2 young diabetic patienis (8.4-20 y r s old) a n d i n 1 0 non-diabetic subjects o f same age. A11 patients had normal fundi a n d uere treated uith insulin injection t w i c e a day. V 
FASTING BLOOD GLUCOSE (BG) LEVELS IN THE LATENT PERIOD (LP) OF IDWM IN CHILDREN.
We retrospectively analyzed the occasional fasting BG concentration o f 21 children and OGTT o f 7 subjects who developed IDDM 60-8 months later. Approaching symptomatic diabetes the fastlng BG levels (72-115 mg/dl) progressively increased with a r-value o f 0.68(p<O.OG5) and the peak insulin releasc at OGTT (40-26 uU/ml) dcclined in a similar linear manner (r=0.97;p<0.01). Abnormal UG elevations in response to OGTT have been noticed in all subjects at 6 0 min. ( > 180 mg/dl)and in 3 of them also at 180 min (> 140 mg/dl);glycosuria appeared in 2 subjects.In spite of these abnormalities BG levels were not further controlled before the overt onset o f IDDM. These retrospective data (rarely avalla ble in the PL o f IDDM in children) confirm that the abrupt clinical onset of diabetes may b e preceeded b y a long period of abnormal BG levels and insulin secretor y capacity. We suggest that monitoring of these parameters may constitute an effective and non-expensive mcasure to identify children at risk for IDDM and to admit them to immunological and genetic investigations
NOCTURNAL SUBCUTANEOUS INSULIN INFUSION IN CHILDREN -EFFICACY AND ACCEPTABILITY
Many younger children consider 24 hour Continuous Subcutaneous Insulin Infusion (CSII) unacceptably intrusive. We have attempted to test an alternative infusion system using a Nocturnal Subcutaneous Insulin Infusion (NSII) which is removed before breakfast at which time an intermediate-acting insulin is injected to cover daytime requirements.
Ten children took part in a cross-over trial of 8 weeks on either conventional insulin treatment (CIT) or NSII. Six prwiwsly well-controlled children (average age 13 years) completed the study. BG profiles showed a significant improvement in the postbreakfast BG level (10.4 mmolll on CIT vs. 8.1 on NSII) but a higher BG before the evening meal (7.5 on CIT vs. 10.3 on NSII). This deterioration in the afternoon profile improved as the trial progressed. Overnight control was good both on CIT and NSII.
Acceptance of NSII was less favourable -only three children elected to stay on an insulin infusion and 12 months after the trial only one child remains on NSII, and another uses it intermittently.
NSII in young children would appear to be effective but more impractical than CIT. 
INSULIN INTERNALIZATION STUDY IN CORD BLOOD ERYTHROCYTES.(E)
Insulin internalization has been extensively studied in tar get cells,this process has not been racterized in human (E). Cord blood (E) were incubated with "'I-insulin at 40C.or at 37'1 C. in the presence and absence of Methylamine (M) which induces intracellular accumulation of insulin or Phenylarsine oxide (P) well known inhibitor of endocytosis.At various time points,insulin binding (f.B.),haemolysis and degradation were determined,and insulin internalization was quantified using an acid extraction technique. Our results show that IM) and (P) failed to alter (I. B.) in (E).Insulin bound at 4'1C. was 90-95% extractable and TCA precipitable while at 37%. with increasing time of incubation the extractability of cell bound insulin and the proportion of ictact,undegraded,extractable insulin decrease. In adition (I.R.) degradation and non-extractable acid insulin were increased by h? emolysis even at 4 " .
In conclusion our (1.B.) values in cord blood (El from preterm and term were 13.224.7 and 7.9'2.2 % x3.3x109(E) or 370 and 257 sites/(E) respectively and the differences were accounted for by a membrane interaction with minimal internalization.
Incubation at low temperature to prevent kaemolysis and degradation must be taken into consideration in (I.B.) studies in (E) for clinical application.
